drugset / Trial / NCT01173926
Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes
RandomizedCrossoverOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this trial is to compare the blood glucose-lowering effect of NN5401 (insulin degludec/insulin aspart, IDegAsp) with NN1250 (insulin degludec, IDeg) and insulin aspart (IAsp) in subjects with type 1 diabetes mellitus.
Timeline
- Start
- 2010-07
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | insulin aspart | Protein / enzyme biologic | — | Subcutaneous |
| Subject | insulin degludec | Protein / enzyme biologic | — | Subcutaneous |
| Subject | insulin degludec/insulin aspart | Unknown | — | Subcutaneous |